Literature DB >> 19299117

Kinome signaling through regulated protein-protein interactions in normal and cancer cells.

Tony Pawson1, Michael Kofler.   

Abstract

The flow of molecular information through normal and oncogenic signaling pathways frequently depends on protein phosphorylation, mediated by specific kinases, and the selective binding of the resulting phosphorylation sites to interaction domains present on downstream targets. This physical and functional interplay of catalytic and interaction domains can be clearly seen in cytoplasmic tyrosine kinases such as Src, Abl, Fes, and ZAP-70. Although the kinase and SH2 domains of these proteins possess similar intrinsic properties of phosphorylating tyrosine residues or binding phosphotyrosine sites, they also undergo intramolecular interactions when linked together, in a fashion that varies from protein to protein. These cooperative interactions can have diverse effects on substrate recognition and kinase activity, and provide a variety of mechanisms to link the stimulation of catalytic activity to substrate recognition. Taken together, these data have suggested how protein kinases, and the signaling pathways in which they are embedded, can evolve complex properties through the stepwise linkage of domains within single polypeptides or multi-protein assemblies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299117     DOI: 10.1016/j.ceb.2009.02.005

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  44 in total

1.  Expression and purification of Src-family kinases for solution NMR studies.

Authors:  Andrea Piserchio; David Cowburn; Ranajeet Ghose
Journal:  Methods Mol Biol       Date:  2012

2.  Independent modulation of the kinase and polo-box activities of Cdc5 protein unravels unique roles in the maintenance of genome stability.

Authors:  Hery Ratsima; Anne-Marie Ladouceur; Mirela Pascariu; Véronique Sauvé; Zeina Salloum; Paul S Maddox; Damien D'Amours
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

Review 3.  Quantitative phosphoproteomics: New technologies and applications in the DNA damage response.

Authors:  Huilin Zhou; Claudio P Albuquerque; Jason Liang; Raymond T Suhandynata; Stephanie Weng
Journal:  Cell Cycle       Date:  2010-09-26       Impact factor: 4.534

Review 4.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

Review 5.  Mechanisms of drug resistance in kinases.

Authors:  Rina Barouch-Bentov; Karsten Sauer
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.206

6.  Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.

Authors:  Amitabha Chaudhuri; Ming-Hong Xie; Becky Yang; Kaushiki Mahapatra; Jinfeng Liu; Scot Marsters; Sweta Bodepudi; Avi Ashkenazi
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

7.  Structure, regulation, signaling, and targeting of abl kinases in cancer.

Authors:  Oliver Hantschel
Journal:  Genes Cancer       Date:  2012-05

8.  Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development.

Authors:  Xiaofeng Zhao; Xu Peng; Shaogang Sun; Ann Y J Park; Jun-Lin Guan
Journal:  J Cell Biol       Date:  2010-06-07       Impact factor: 10.539

9.  The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis.

Authors:  Svenja Beckmann; Christin Buro; Colette Dissous; Jörg Hirzmann; Christoph G Grevelding
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

Review 10.  The ubiquitin landscape at DNA double-strand breaks.

Authors:  Troy E Messick; Roger A Greenberg
Journal:  J Cell Biol       Date:  2009-11-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.